ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Accent Microcell transcript for FY26 results highlights growth driven by high-value premium products (MCC spheres, SMCC) and upcoming capacity expansion via Unit 3.
Accent Microcell reported FY26 revenue of ₹34,903 Lakhs (up 31.92% YoY) and PAT of ₹4,385 Lakhs (up 32.65% YoY), driven by strong export growth and expansion in pharmaceutical excipients.
Accent Microcell delivered record H2 results driven by a strategic shift toward premium products like MCC spheres, though Unit 3 delays at Navagam remain a point of concern for immediate scaling.
Accent Microcell Ltd reported revenue from operations of ₹209.7 Cr (+51.4% YoY) and net profit of ₹25.8 Cr (+55.4% YoY) for H2 FY26.